ESC – 13thCongress and call for applications for project funding

Mark your calendar: 28 till 31 May 2014 Lisbon, Portugal First announcement Check out the first announcement including: programme overview: 8 workshops, 21 congress sessions, 2 debates… abstract submission instructions (deadline 1 December 2013) registration form Register now Please find here an overview of the registration fees. You can now register through the online registration form General […]

Read More…

World Contraception Day – 26 September 2013

WCD will be using an umbrella theme for this and future years: ‘Its your life; its your future’. This theme has been chosen as it is forward-looking, positive and empowering. There are 3 sub-themes: Your options: where young people can learn about all the contraceptive options available, using a reliable, unbiased source of information. Your […]

Read More…

Faculty 20th Anniversary Celebration & McGonagall’s Ode!

At the event to celebrate the Faculty’s 20th anniversary, those gathered were regaled, by the invited after-dinner speaker Professor James Drife, with the following ode – available as a podcast for best effect: The Editor felt the Journal’s readers might like to share the experience, although nothing could compare with seeing the performance ‘live’. When […]

Read More…

July Journal published as Impact Factor soars to 2.1!

The July edition of the Journal is now available online and includes: Venous thromboembolism and COCs: an ongoing saga This ongoing controversy recently resulted in the decision of the French authorities to withdraw the combined oral contraceptive (COC) containing ethinylestradiol (EE) and cyproterone acetate (i.e. Diane 35®) from the market. This consensus statement from 26 […]

Read More…

New injectable – Sayana Press and Dianette VTE update

Sayana Press® is a progestogen-only injectable contraceptive licensed for subcutaneous use. It contains 104mg of medroxyprogesterone acetate (MPA) in 0.65ml suspension and is bioequivalent to IM depot medroxyprogesterone acetate. It is administered at intervals of 13 weeks +/- 7 days via a new delivery system (Unijet) – a single dose pre-filled injector. Although ideal for […]

Read More…

Copenhagen Impressions

European Society of Contraception and Reproductive Health First Global Conference Highlights of the Congress included: Crown Princess Mary opening the Congress followed by the amazing Copenhagen drummers                                Green contraception – estrogen in water an issue, rating methods for their ‘greenness’: hormones, packaging etc. Lidegaard / Shulman / Dinger – continuing debate on […]

Read More…

Help WHO revise its guidelines!

The WHO are currently preparing updates to its Medical Eligibility Criteria for Contraceptive Use and Selected Practice Recommendations for Contraceptive Use, which will be finalized in 2014, and are soliciting feedback from various stakeholders in the field of family planning to inform this process. The goal is to ensure these guidelines remain relevant to family planning […]

Read More…

US Judge orders FDA to make Morning-After Pill available over the counter for all

 Judge Strikes Down Age Limits on Morning-After Pill A federal judge has ruled that the Unites States government must make the most common morning-after pill available over the counter for all ages, instead of requiring a prescription for girls 16 and under. The New York Times reported that the decision, on a fraught and politically […]

Read More…

April Journal – 20th Anniversary of the FSRH

Hightlights from this edition include: The FSRH’s 20th anniversary It is 20 years since the establishment of the Faculty of Sexual and Reproductive Healthcare (FSRH). In celebrating its anniversary there is much to be proud of, and indeed Community Sexual and Reproductive Health is now a specialty in its own right. Readers should find the story […]

Read More…